Interaction of purulent material with antibiotics used to treat Pseudomonas infections
- PMID: 4375433
- PMCID: PMC444723
- DOI: 10.1128/AAC.6.6.702
Interaction of purulent material with antibiotics used to treat Pseudomonas infections
Abstract
To define factors contributing to the adverse prognosis of patients with gram-negative bacillemia and abscess formation, we studied the interaction between polymyxin B, colistin sulfate, gentamicin, or carbenicillin with purulent material. Carbenicillin activity was not significantly altered by incubation with pus. Equal volumes of antibiotic and purulent sediment decreased the effective concentration of polymyxin B, colistin sulfate, or gentamicin from 100 mug/ml to 3 to 6 mug/ml. One milliliter of purulent sediment bound more than 700 mug of gentamicin and 1,500 mug of polymyxin B or colistin sulfate. This effect occurred rapidly, proceeded at 4 and 37 C, was stable for 24 to 48 h, and was altered, but not abolished, by varying the pH of the solution. Antibiotic activity could be removed from pus by high concentrations of protamine sulfate, heparin, sodium chloride, or potassium chloride, suggesting binding rather than inactivation.
Similar articles
-
Comparison of tobramycin, gentamicin, colistin, and carbenicillin in Pseudomonas sepsis in monkeys.Antimicrob Agents Chemother. 1972 Sep;2(3):164-72. doi: 10.1128/AAC.2.3.164. Antimicrob Agents Chemother. 1972. PMID: 4208275 Free PMC article.
-
Carbenicillin and other antibiotics for therapy of Pseudomonas infections.Med Lett Drugs Ther. 1970 Dec 11;12(25):101-3. Med Lett Drugs Ther. 1970. PMID: 4328250 No abstract available.
-
Topical antibiotic therapy of Pseudomonas aeruginosa keratitis.Arch Ophthalmol. 1979 Sep;97(9):1699-1702. doi: 10.1001/archopht.1979.01020020267016. Arch Ophthalmol. 1979. PMID: 224848
-
Pseudomonas aeruginosa infections.CRC Crit Rev Clin Lab Sci. 1972 Sep;3(3):291-347. doi: 10.3109/10408367209151698. CRC Crit Rev Clin Lab Sci. 1972. PMID: 4376736 Review. No abstract available.
-
[Anti-Pseudomonas aerosol therapy in cystic fibrosis: improvement with tobramycin].Rev Pneumol Clin. 2002 Jun;58(3 Pt 1):131-8. Rev Pneumol Clin. 2002. PMID: 12486796 Review. French.
Cited by
-
Renal pharmacokinetic changes of gentamicin during enterococcal pyelonephritis.Antimicrob Agents Chemother. 1988 May;32(5):736-9. doi: 10.1128/AAC.32.5.736. Antimicrob Agents Chemother. 1988. PMID: 3134849 Free PMC article.
-
Gentamicin antibacterial activity in the presence of human polymorphonuclear leukocytes.Antimicrob Agents Chemother. 1979 Dec;16(6):743-9. doi: 10.1128/AAC.16.6.743. Antimicrob Agents Chemother. 1979. PMID: 533256 Free PMC article.
-
Influence of inflammation on the efficacy of antibiotic treatment of experimental pyelonephritis.Antimicrob Agents Chemother. 1986 May;29(5):760-4. doi: 10.1128/AAC.29.5.760. Antimicrob Agents Chemother. 1986. PMID: 3524429 Free PMC article.
-
Macromolecular mechanisms of sputum inhibition of tobramycin activity.Antimicrob Agents Chemother. 1995 Jan;39(1):34-9. doi: 10.1128/AAC.39.1.34. Antimicrob Agents Chemother. 1995. PMID: 7535039 Free PMC article.
-
Inhibition of antibiotic activity in vitro by synthetic melanin.Antimicrob Agents Chemother. 1976 Sep;10(3):569-70. doi: 10.1128/AAC.10.3.569. Antimicrob Agents Chemother. 1976. PMID: 984797 Free PMC article.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources